Clinical Trials in Pittsburgh

Showing 2421-2440 of 18,076 trials

BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

NCT06632496

This post-market study is being conducted to generate safety and performance data on the BD Prevue(TM) II Peripheral Vascular Access System with Cue(TM) Needle Tracking Technology. The data will be utilized to support regional registrations (for example, EU MDR), and document any unforeseen residual risks.

BD Prevue II for Peripheral Intravenous Catheter Placement

Becton, Dickinson and Company156 participantsStarted Mar 2025

Brooklyn, New York, United States • Pittsburgh, Pennsylvania, United States

RECRUITINGNA< 1 mile

Assessment of CCM in HF With Higher Ejection Fraction

NCT05064709

The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥40% and ≤70%.

Heart FailureHeart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection Fraction+2 more

Impulse Dynamics1,500 participantsStarted Feb 2022

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Mesa, Arizona, United States +109 more locations

BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

Assessment of CCM in HF With Higher Ejection Fraction

Find Trials by Condition in Pittsburgh

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System

A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

iHERO Study: Insurance, Health and Economic Resources Online for Emerging Adults With Type 1 Diabetes

Study of Serine Supplementation to Protect Vision in MacTel

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

A Study of DM005 in Patients With Advanced Solid Tumors

Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia

@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms

855303-RNA Biomarker Validation

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Harm Reduction for Smokers With Mental Illness

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies